UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: SertralinTeva50mgfilmtablett-SE-PLC-MPD-BBDL

Sertralin Teva 50 mg filmdragerad tablett

MPID: SE-100001594-00023781
EURDID: 2696

Full name: Sertralin Teva 50 mg filmdragerad tablett

- Scientific name part: Sertralin Teva

- Strength part: 50 mg

- Pharmaceutical dose form part: filmdragerad tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Film-coated tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097678 sertraline

Marketing Authorisation 1 of 1

Authorisation number: 23781

Region: Kingdom of Sweden

Marketing authorisation holder: Teva Sweden AB

Identifier:

  • LOC-100001602

Status: Valid (2007-01-26)

Package 1 of 3

PCID:

Description:
Blister, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 10 Blister (Aluminium) (PolyVinyl Chloride) (PolyVinylidene Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Sertraline hydrochloride

Presentation strength: 55.96 milligram(s) / 1 Tablet

Reference strength:
Sertraline 50 milligram(s) / 1 Tablet

Package 2 of 3

PCID:

Description:
Blister, 30 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 3 Blister (Aluminium) (PolyVinyl Chloride) (PolyVinylidene Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Sertraline hydrochloride

Presentation strength: 55.96 milligram(s) / 1 Tablet

Reference strength:
Sertraline 50 milligram(s) / 1 Tablet

Package 3 of 3

PCID:

Description:
Blister, 250 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 250 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 25 Blister (Aluminium) (PolyVinyl Chloride) (PolyVinylidene Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Sertraline hydrochloride

Presentation strength: 55.96 milligram(s) / 1 Tablet

Reference strength:
Sertraline 50 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Film-coated tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Sertraline hydrochloride

Presentation strength: 55.96 milligram(s) / 1 Tablet

Reference strength:
Sertraline 50 milligram(s) / 1 Tablet